Clinical Trial Report

Topical Anti-TNFα Agent Licaminlimab (OCS-02) Relieves Persistent Ocular Discomfort in Severe Dry Eye Disease: A Randomized Phase II Study

Shettle L, McLaurin E, Martel J, Seaman JW III, Weissgerber G

Clinical Ophthalmology 2022, 16:2167-2177

Published Date: 6 July 2022